Director boosts InspireMD (NSPR) stake with 90,000-share buy

Rhea-AI Filing Summary

InspireMD, Inc. director Gary S. Roubin made an open-market purchase of 90,000 shares of Common Stock. He bought the shares at a weighted average price of $1.18 per share, through multiple trades between $1.15 and $1.20. Following this transaction, he directly owns 834,478 shares, increasing his personal stake in the company.

Insider Trade Summary

Net Buyer: 90,000 shares ($106,200)

Net Buy 1 txn

Insider ROUBIN GARY S

Role null

Bought 90,000 shs ($106K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	90,000	$1.18	$106K

Holdings After Transaction: Common Stock — 834,478 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 90,000 shares Weighted average purchase price: $1.18 per share Post-transaction holdings: 834,478 shares +1 more

4 metrics

Shares purchased 90,000 shares Open-market purchase of InspireMD Common Stock

Weighted average purchase price $1.18 per share Average price across multiple trades on the transaction date

Post-transaction holdings 834,478 shares Direct ownership after the reported purchase

Trade price range $1.15–$1.20 per share Range of individual trade prices for the 90,000 shares

Key Terms

open-market purchase, weighted average price, Securities and Exchange Commission

3 terms

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Securities and Exchange Commission regulatory

"or the staff of the Securities and Exchange Commission, upon request"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROUBIN GARY S

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FLORIDA 33126

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		P		90,000	A	$1.18(1)	834,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Michael Lawless, Attorney-in-Fact for Gary S. Roubin	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did InspireMD (NSPR) director Gary S. Roubin report?

Gary S. Roubin reported an open-market purchase of 90,000 InspireMD common shares. He bought the stock at a weighted average price of $1.18 per share, increasing his direct ownership to 834,478 shares following the transaction.

At what price did Gary S. Roubin buy InspireMD (NSPR) shares in his Form 4?

Roubin’s purchase carried a weighted average price of $1.18 per InspireMD share. The filing notes multiple trades were executed in a range between $1.15 and $1.20 per share, all on the same reported transaction date.

How many InspireMD (NSPR) shares does Gary S. Roubin own after this transaction?

After buying 90,000 additional shares, Roubin directly owns 834,478 InspireMD common shares. This figure reflects his holdings immediately following the reported open-market purchase and shows the scale of his ongoing ownership position in the company.

What does the price range disclosure mean in the InspireMD (NSPR) Form 4?

The Form 4 states the 90,000 shares were bought in multiple trades between $1.15 and $1.20. The $1.18 reported price is a weighted average, and Roubin undertakes to provide full trade-by-trade price details to the issuer, shareholders, or SEC staff upon request.

Is Gary S. Roubin’s InspireMD (NSPR) transaction a purchase or sale?

Roubin’s Form 4 reflects a purchase, not a sale, of InspireMD common stock. The transaction code is “P,” indicating an open-market or private purchase, and the filing classifies the direction as a buy of 90,000 shares.